[Acute nonmyeloid leukemia in adults. Study of membrane antigens and terminal transferase. Diagnostic and prognostic value]

Autor: Ifrah N, Jy, Perrot, Jp, Marie, Rio B, Julien C, Cadiou M, Claude Boucheix, Zittoun R

Publikováno v: Europe PubMed Central

Between January, 1982 and April, 1983, 92 adult patients with acute leukaemia were investigated in our department. According to classical criteria (cytology and optical cytochemistry), 34 were classified as "non-myeloid". These were further tested wi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::9639de39ca558198d34b8d24c5a10eda
https://pubmed.ncbi.nlm.nih.gov/3156336

[Ultrastructural peroxidases and immunological markers in acute adult leukaemia: therapeutic applications (author's transl)]

Autor: Jp, Marie, Escribano L, Jy, Perrot, Claude Boucheix, Kayibanda M, Mc, Martyre, Cadiou M, Rosenfeld C, Zittoun R

Publikováno v: Europe PubMed Central

In a retrospective study of 112 adult patients with acute leukaemia (AL), the percentage of undifferentiated leukaemia was reduced to almost 1% by an analysis of routine cytochemical reactions (PAS, peroxidase, esterases and esterase inhibition), B a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::84ec73ae38c611a391583b7d0eb161fa
https://pubmed.ncbi.nlm.nih.gov/7048250

[A specific marker of thrombolysis: DDE complex]

Autor: Soria J, Soria C, Mirshahi M, Claude Boucheix, Pujade E, Jy, Perrot, Samama M, Bernadou A, Jp, Caen

Publikováno v: Europe PubMed Central

A specific determination of fibrin degradation product (FbDP) is essential for the monitoring of thrombolytic therapy. In patients under thrombolytic therapy, even with tpA (tissue type plasminogen activator) fibrinogen is degraded, and fragment D de

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::11735dbf0c69bcbb12204b6a58f8f31e
http://europepmc.org/abstract/med/3103876

Measuring multidrug resistance expression in human malignancies: elaboration of consensus recommendations

Autor: Jp, Marie, Legrand O, Jy, Perrot, Sylvie Chevillard, Huet S, Robert J

Publikováno v: Europe PubMed Central

Before the prognostic significance of P-glycoprotein (P-gp) expression can be properly evaluated in prospective clinical trials of P-gp modulators, standard techniques for the measurement of P-gp must be widely accepted. Several multicenter trials ha

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::8af12a0adfcc4f1874cc393e3fe00651
http://europepmc.org/abstract/med/9408962

The level of blast CD33 expression positively impacts the effect of gemtuzumab ozogamicin in patients with acute myeloid leukemia.

Autor: Olombel G; Laboratoire d'Hématologie et Unité Mixte de Recherche 7276 Centre National de la Recherche Scientifique, Centre Hospitalier Universitaire (CHU) de Limoges, Faculté de Médecine, Université de Limoges et Centre National de la Recherche Scientifique, Limoges, France;, Guerin E; Laboratoire d'Hématologie et Unité Mixte de Recherche 7276 Centre National de la Recherche Scientifique, Centre Hospitalier Universitaire (CHU) de Limoges, Faculté de Médecine, Université de Limoges et Centre National de la Recherche Scientifique, Limoges, France;, Guy J; Service d'Hématologie Biologique, CHU, Dijon, France;, Perrot JY; Service d'Hématologie Biologique, Hôpital Saint Antoine, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France;, Dumezy F; Laboratoire d'Hématologie, CHU, Lille, France;, de Labarthe A; Service d'Hématologie Adulte, Hôpital Saint-Louis, AP-HP, Université Paris Diderot, Paris, France;, Bastie JN; Service d'Hématologie, CHU, Dijon, France;, Legrand O; Service d'Hématologie, Hôtel Dieu, Hôpital Saint Antoine, AP-HP, Paris, France;, Raffoux E; Service d'Hématologie Adulte, Hôpital Saint-Louis, AP-HP, Université Paris Diderot, Paris, France;, Plesa A; Centre de Biologie et d'Anatomie Pathologique, Hématologie Cellulaire et Immunophénotypage des hémopathies, CHU de Lyon-Hospices Civils de Lyon, Pierre Bénite, France;, Wagner-Ballon O; Département d'Hématologie et Immunologie Biologiques, Hôpitaux universitaire Henri Mondor, AP-HP, University Paris-Est Créteil, Créteil, France;, Cornet E; Laboratoire d'Hématologie, CHU, Caen, France;, Salaun V; Laboratoire d'Hématologie, CHU, Caen, France;, Preudhomme C; Laboratoire d'Hématologie, CHU, Lille, France;, Thomas X; Service d'Hématologie, Centre Hospitalier Lyon Sud, Pierre-Bénite, France;, Pautas C; Service d'Hématologie Clinique, Hôpital Henri Mondor, AP-HP, Créteil, France;, Chantepie S; Service d'Hématologie, CHU, Caen, France;, Turlure P; Service d'Hématologie, CHU, Limoges, France; and., Castaigne S; Service d'Hématologie-Oncologie, Centre Hospitalier, Versailles, France., Dombret H; Service d'Hématologie Adulte, Hôpital Saint-Louis, AP-HP, Université Paris Diderot, Paris, France;, Feuillard J; Laboratoire d'Hématologie et Unité Mixte de Recherche 7276 Centre National de la Recherche Scientifique, Centre Hospitalier Universitaire (CHU) de Limoges, Faculté de Médecine, Université de Limoges et Centre National de la Recherche Scientifique, Limoges, France;

Publikováno v: Blood [Blood] 2016 Apr 28; Vol. 127 (17), pp. 2157-60. Date of Electronic Publication: 2016 Feb 29.